Search research articles
Contact Us
Filters
Showing results (41-50 of 100) with videos related to
Page
of 10
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits
N Kambham, G S Markowitz, N Tanji, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
March 23, 2000
Are nucleated red cells significant in patients with thrombotic thrombocytopenic purpura?
L J McCarthy, C Danielson, E Skipworth, et al.
Experimental Hematology
|
January 16, 1998
Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells
C M Traycoff, A Orazi, A C Ladd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 1, 1996
mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected]
J H Haidar, R S Neiman, A Orazi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma
A M Gianni, M Bregni, S Siena, et al.
Cancer
|
June 15, 1993
Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors
A Orazi, R S Neiman, T M Ulbright, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
A 51-year-old female with nephrotic syndrome, renal failure, and hepatitis c virus infection
G Markowitz, P Kaur, A Orazi, et al.
Blood
|
May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow
A Orazi, G Cattoretti, R Schiró, et al.
Blood Cells, Molecules & Diseases
|
June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer
H E Broxmeyer, A Orazi, N L Hague, et al.
Haematologica
|
July 1, 1989
Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis
M Bregni, M G Borrello, S Siena, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 100) with videos related to
Sort By:
Page
of 10
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits
N Kambham, G S Markowitz, N Tanji, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|
March 23, 2000
Are nucleated red cells significant in patients with thrombotic thrombocytopenic purpura?
L J McCarthy, C Danielson, E Skipworth, et al.
Experimental Hematology
|
January 16, 1998
Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells
C M Traycoff, A Orazi, A C Ladd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 1, 1996
mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected]
J H Haidar, R S Neiman, A Orazi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1990
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma
A M Gianni, M Bregni, S Siena, et al.
Cancer
|
June 15, 1993
Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors
A Orazi, R S Neiman, T M Ulbright, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2001
A 51-year-old female with nephrotic syndrome, renal failure, and hepatitis c virus infection
G Markowitz, P Kaur, A Orazi, et al.
Blood
|
May 15, 1992
Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow
A Orazi, G Cattoretti, R Schiró, et al.
Blood Cells, Molecules & Diseases
|
June 6, 1998
Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer
H E Broxmeyer, A Orazi, N L Hague, et al.
Haematologica
|
July 1, 1989
Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis
M Bregni, M G Borrello, S Siena, et al.
Page
of 10